Coffee Intake in Midlife and Risk of Dementia and its Neuropathologic Correlates
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
While animal data suggest a protective effect of caffeine on cognition, studies in humans remain inconsistent. We examined associations of coffee and caffeine intake in midlife with risk of dementia, its neuropathologic correlates, and cognitive impairment among 3494 men in the Honolulu-Asia Aging Study (mean age 52 at cohort entry, 1965-1968) examined for dementia in 1991-1993, including 418 decedents (1992-2004) who underwent brain autopsy. Caffeine intake was determined according to self-reported coffee, tea, and cola consumption at baseline. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for overall dementia, Alzheimer's disease (AD), vascular dementia (VaD), cognitive impairment (Cognitive Abilities Screening Instrument score <74), and neuropathologic lesions at death (Alzheimer lesions, microvascular ischemic lesions, cortical Lewy bodies, hippocampal sclerosis, generalized atrophy), according to coffee and caffeine intake. Dementia was diagnosed in 226 men (including 118 AD, 80 VaD), and cognitive impairment in 347. There were no significant associations between coffee or caffeine intake and risk of cognitive impairment, overall dementia, AD, VaD, or moderate/high levels of the individual neuropathologic lesion types. However, men in the highest quartile of caffeine intake (>/=411.0 mg/d) [corrected] were less likely than men in the lowest quartile (</=137.0 mg) [corrected] to have any of the lesion types (adjusted-OR, 0.45; 95% CI, 0.23-0.89; p, trend = 0.04). Coffee and caffeine intake in midlife were not associated with cognitive impairment, dementia, or individual neuropathologic lesions, although higher caffeine intake was associated with a lower odds of having any of the lesion types at autopsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The remaining cohort studies (3 of 11, 27%) did not find an association between caffeine intake and cognitive change [161] or incident dementia [166,174].”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [174]
In the citing paper
“Finally, large cohort studies of men and women have also found an inverse relationship between caffeine consumption and the risk of Parkinson’s disease (90–92) and Alzheimer’s disease (93–95).”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [95]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 1×
“receptor antagonist, acts as a brain stimulant acutely 324 and enhances alertness [21].”
BackgroundThe Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised
Kobylski, T. P. (1988) · Psychosomatics · doi:10.1016/s0033-3182(88)72438-x · Cited by 1,054
Teng, E. L., Hasegawa, K., Homma, A., Imai, Y., Larson, E., Graves, A., Sugimoto, K., Yamaguchi, T., Sasaki, H., Chiu, D., et al. (1994) · International Psychogeriatrics · doi:10.1017/s1041610294001602 · Cited by 926
Self-citationAssociation of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Self-citationWalking and Dementia in Physically Capable Elderly Men
Abbott, R. D. (2004) · JAMA · doi:10.1001/jama.292.12.1447 · Cited by 743 · cited 1×
“This corresponds approximately to a score of 22 on the Mini-Mental State Examination, a level often used to indicate cognitive impairment [13].”
Self-citationArendash, G. W., Schleif, W., Rezai-Zadeh, K., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 457
Cited by
Items 101–148 of 148
Dietary Components and Nutritional Strategies for Dementia Prevention in the Elderly
Cao, X., Xu, W., Wang, Z.-T., Tan, L., & Yu, J.-T. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230609155932 · Cited by 5
Moderate coffee and tea consumption is associated with slower cognitive decline
Rainey‐Smith, S. R., Sewell, K. R., Brown, B. M., Sohrabi, H. R., Martins, R. N., & Gardener, S. L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251361058 · Cited by 4
Barbagallo, M., Springer, A., Vanetta, C., Allemann, M., Lee, P., Saravi, S. S. S., Aeschbacher, S., Luciani, M., Bonati, L. H., Moschovitis, G., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034365 · Cited by 4
Coffee and Alzheimer's Disease—Epidemiologic Evidence
Lindsay, J., Carmichael, P., Kröger, E., & Laurin, D. (2012) · Wiley eBooks · doi:10.1002/9781119949893.ch5 · Cited by 4
Coffee: chemical composition, antioxidant activity and effects on human health
Interlab, Yashin, A. Y., Levin, D. A., Interlab, Levina, L., Interlab, Vedenin, A. N., Interlab, Yashin, Y. I., & Interlab (2020) · Laboratory and production · doi:10.32757/2619-0923.2020.2.12.88.102 · Cited by 4
Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s Disease
Dominguez, L. J., & Barbagallo, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815238-6.00015-8 · Cited by 4
Lim, T. K. (2012) · Springer eBooks · doi:10.1007/978-94-007-5653-3_32 · Cited by 4
Mazzoleni, E., Malavolti, M., Rossetti, A. O., Mazzoli, R., Vinceti, M., & Filippini, T. (2026) · Journal of Epidemiology and Population Health · doi:10.1016/j.jeph.2026.203168 · Cited by 3
David, S. R. N., Hussain, R. D. Z., Zulkipli, I. N., & Rajabalaya, R. (2022) · International Journal of Food Studies · doi:10.7455/ijfs/11.2.2022.a10 · Cited by 3
Is caffeine a potential therapeutic intervention for Alzheimer's disease?
Zhai, Y., Yelanchezian, Y. M. M., & Kwakowsky, A. (2023) · Brain Network and Modulation · doi:10.4103/2773-2398.379339 · Cited by 3
Does dietary intake of caffeine have an effect on transient global amnesia?
Zeinalabedini, M., Mousavi, Z. S., Amjadi, A., Shapouri, M., Kavkani, B. A., Masoumvand, M., Mobarakeh, K. A., Gholamalizadeh, M., Valisoltani, N., Mohammadi, S., et al. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12408 · Cited by 3
Li, T., Fili, M., Mohammadiarvejeh, P., Dawson, A. L., Hu, G., & Willette, A. A. (2024) · Nutrients · doi:10.3390/nu16244303 · Cited by 3
Naha, N., Das, M., & Banerjee, A. (2018) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000309 · Cited by 3
Коган, М. И., & Jeong, H.-S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00011-6 · Cited by 2
Serrano‐Marín, J., Valenzuela, R., Delgado, C., Quijano, A., Navarro, G., Labandeira-García, J. L., & Franco, R. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101934 · Cited by 2
Oseid, D. E., Song, L., Lear, S. K., & Robinson, A. S. (2020) · Steroids · doi:10.1016/j.steroids.2020.108641 · Cited by 2
Förstl, H., & Förstl, S. (2020) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-55793-8_58-1 · Cited by 2
The Adenosine Receptor: A Homeostatic Neuromodulator for Fine-Tuning Control of Cognition
Chen, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_15 · Cited by 2
Coffee and the Risk of Dementia and Cognitive Impairment
Gelber, R. P., & White, L. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00082-3 · Cited by 1
Self-citationPLANTAS MEDICINAIS PERSPECTIVAS DE USOS NO TRATAMENTO DA DOENÇA DE ALZHEIMER
Feitosa, C. M., Lima, L. K. F., & Rai, M. (2020) · doi:10.22533/at.ed.3682006026 · Cited by 1
Förstl, H., & Förstl, S. (2021) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-62426-5_58 · Cited by 1
Neuroproteção por cafeína em modelo animal de Doença de Alzheimer
Teixeira, J. E. (2015) · Americanae (AECID Library) · Cited by 1
Conception, synthèse et évaluation d'antagonistes des récepteurs A2A
Duroux, R. (2017) · theses.fr (ABES) · doi:10.70675/f23c0e8bzbf16z4c46zb459za427796dbff2 · Cited by 1
Luis, J., Alberto, C., Barrachina, M., Ferrer, I., & Marti, M. (2011) · InTech eBooks · doi:10.5772/17842
Evidence Surrounding the Relation between Coffee and Cognitive Function
M.S, D. M. B., Greer, C. E., Isaacson, R., & Ochner, C. N. (2014)
Adenosine A2A Receptor-Mediated Control of Non-Motor Functions in Parkinson’s Disease
Prediger, R. D., MATHEUS, F. C., de Oliveira, P. A., Rial, D., Moretti, M., Souza, A. C. G., Aguiar, A. S., & Cunha, R. A. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-20273-0_10
Park, G. H., & Jang, J. (2015) · Springer eBooks · doi:10.1007/978-4-431-55763-0_21
Adenosine Receptors and Memory Disorders
de Mendonça, A., Blum, D., & Geiger, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803724-9.00009-0
Astrocytic A2A receptors: Novel targets to manage brain disorders
Henriques, V. J., Gonçalves, N., Agostinho, P. M., & Cunha, R. A. (2017) · Porto Biomedical Journal · doi:10.1016/j.pbj.2017.07.011
Dietary Patterns, Foods and Beverages in Age-Related Cognitive Performance and Dementia
Dreher, M. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-59180-3_18
コーヒー/カフェイン摂取と日常生活 : カフェインと神経変性疾患リスクの評価
栗原, 久. (2017) · Institutional Repositories DataBase (IRDB)
Ruokavalion ja syömisen taidon yhteys kognitiiviseen toimintakykyyn
Kaulio, M. (2020) · UEF eRepo (University of Eastern Finland)
The Impact of Maternal High Fat Diet and Caffeine Exposure on Maternal and Offspring Health
Szeto, V. (2019) · TSpace (University of Toronto)
Potential Neuromodulatory Profile of Phytocompounds in Brain Disorders
Trabace, L. (2017) · MDPI eBooks · doi:10.3390/books978-3-03842-317-1
A2AR and traumatic brain injury
Zhao, Y., Ning, Y., & Zhou, Y. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.07.006
Study on metabolic pathway of mild cognitive impairment in type 2 diabetes patientsPreprint
Liu, W., Zhou, Y., Qiu, J., Gao, C., Pan, C., & Guo, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3919361/v1
Rôle des récepteurs adénosinergiques A2A dans la maladie d'Alzheimer
Carvalho, K. (2019) · theses.fr (ABES) · doi:10.70675/d82717c2z3bb4z4a19za654zee23c014afae
Instituto de pesquisa café e saúde: Prevenção de doenças e melhora da qualidade de vida
Cunha, R. A., Rohden, F., & Souza, D. O. (2024) · Research Society and Development · doi:10.33448/rsd-v13i5.45666
Smart foods and neurodegeneration: Exploring future therapeutic avenues
Cheng, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00034-8
Cicero, A. F. G., & Micoli, V. D. (2025) · Springer eBooks · doi:10.1007/978-3-031-93459-9_7
Rabelo Bezerra, J., & Andrade, G. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.5281/zenodo.13799392
O papel dos receptores de adenosina A2A em astrócitos - implicações para a actividade glutamatérgica
Matos, M. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Cognitive Disorders and Impact of Nutrition: An Updated Review.
Alshebel, K. A. (2024) · Review of Contemporary Philosophy
Gardener, S. L., Rainey-Smith, S. R., Villemagne, V. L., Fripp, J., Doré, V., Bourgeat, P., Taddei, K., Fowler, C., Masters, C. L., Maruff, P., et al. (2021) · doi:10.3389/fnagi.2021.744872.s001
Zhang, Y., Yang, H., Li, S., Li, W.-D., & Wang, Y. (2021) · doi:10.1371/journal.pmed.1003830.r002
Ji, S., Sun, H., Jin, X., Chen, B., Zhou, J., Zhao, J., Liang, X., Shen, W., Zhang, Y., & Chan, P. (2022) · doi:10.3389/fneur.2022.977641.s001
Caffeine and neurodegenerative disorders
Szopa, A., & Poleszak, E. (2014) · Medicina internacia revuo
Metadata
- Authors
- Gelber, R. P., Petrovitch, H., Masaki, K. H., Ross, G. W., & White, L. R.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Corresponding author
- Gelber, Rebecca P.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2011-03-21
- Volume
- 23
- Issue
- 4
- Pages
- 607-615
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC3731132
- OpenAlex
- W2161647071
- Cited by
- 133
- References
- 31
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 9 · 2023: 10 · 2022: 9 · 2021: 17 · 2020: 8 · 2019: 6 · 2018: 11 · 2017: 10 · 2016: 14 · 2015: 9 · 2014: 14 · 2013: 7 · 2012: 4
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-08-05)
- Open access
- green
- europepmc.org
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01ag019349-08, 5u01ag017155-10)
- National Institute on Aging (U01-AG017155, 3U01 AG017155-09S1, 5U01AG017155‐09, 5U01 AG19349-09, U01-AG019349)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- coffee consumption, caffeine
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Asian, Brain, Caffeine, Coffee, Cognition Disorders, Dementia, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Tea, Dementia, Vascular, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.